Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: DC-CIK Immunotherapy|DRUG: Capecitabine Monotherapy
Sponsor: The First People's Hospital of Changzhou